Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Engen

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Nature Communications|February 12, 2022
Allosteric control of Ubp6 and the proteasome via a bidirectional switchKa Ying Sharon Hung, Sven Klumpe, Markus R Eisele, et al.
Molecular Cell|June 14, 2020
Homogeneous Oligomers of Pro-apoptotic BAX Reveal Structural Determinants of Mitochondrial Membrane PermeabilizationZachary J Hauseman, Edward P Harvey, Catherine E Newman, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
A druggable redox switch on SHP1 controls macrophage inflammationMei Ying Ng, Meredith N Nix, Guangyan Du, et al.
Nature Chemical Biology|March 13, 2026
A druggable redox switch on SHP1 controls macrophage inflammationMei Ying Ng, Meredith N Nix, Guangyan Du, et al.
Cell|November 22, 2025
Inhibition of oligomeric BAX by an anti-apoptotic dimerCatherine E Newman, Micah A Gygi, Haleh Alimohamadi, et al.
Molecular Cell|June 2, 2023
Irisin acts through its integrin receptor in a two-step process involving extracellular Hsp90αMu A, Thomas E Wales, Haixia Zhou, et al.
Nature Communications|December 20, 2012
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitorsWenyu Yu, Emma J Chory, Amy K Wernimont, et al.
Nature|January 15, 2010
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitorsJianming Zhang, Francisco J Adrián, Wolfgang Jahnke, et al.
Scientific Reports|March 27, 2020
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanismNathan J Schauer, Xiaoxi Liu, Robert S Magin, et al.
Cancer Discovery|April 7, 2019
Tissue-Specific Oncogenic Activity of KRAS<sup>A146T</sup>Emily J Poulin, Asim K Bera, Jia Lu, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Nature Communications|February 12, 2022
Allosteric control of Ubp6 and the proteasome via a bidirectional switchKa Ying Sharon Hung, Sven Klumpe, Markus R Eisele, et al.
Molecular Cell|June 14, 2020
Homogeneous Oligomers of Pro-apoptotic BAX Reveal Structural Determinants of Mitochondrial Membrane PermeabilizationZachary J Hauseman, Edward P Harvey, Catherine E Newman, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
A druggable redox switch on SHP1 controls macrophage inflammationMei Ying Ng, Meredith N Nix, Guangyan Du, et al.
Nature Chemical Biology|March 13, 2026
A druggable redox switch on SHP1 controls macrophage inflammationMei Ying Ng, Meredith N Nix, Guangyan Du, et al.
Cell|November 22, 2025
Inhibition of oligomeric BAX by an anti-apoptotic dimerCatherine E Newman, Micah A Gygi, Haleh Alimohamadi, et al.
Molecular Cell|June 2, 2023
Irisin acts through its integrin receptor in a two-step process involving extracellular Hsp90αMu A, Thomas E Wales, Haixia Zhou, et al.
Nature Communications|December 20, 2012
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitorsWenyu Yu, Emma J Chory, Amy K Wernimont, et al.
Nature|January 15, 2010
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitorsJianming Zhang, Francisco J Adrián, Wolfgang Jahnke, et al.
Scientific Reports|March 27, 2020
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanismNathan J Schauer, Xiaoxi Liu, Robert S Magin, et al.
Cancer Discovery|April 7, 2019
Tissue-Specific Oncogenic Activity of KRAS<sup>A146T</sup>Emily J Poulin, Asim K Bera, Jia Lu, et al.
Pageof 20